RYVPX vs. NCLEX
Compare and contrast key facts about Royce Smaller-Companies Growth Fund (RYVPX) and Nicholas Limited Edition Fund (NCLEX).
RYVPX is managed by Royce Investment Partners. It was launched on Jun 14, 2001. NCLEX is managed by Nicholas. It was launched on May 18, 1987.
Performance
RYVPX vs. NCLEX - Performance Comparison
Loading graphics...
RYVPX vs. NCLEX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RYVPX Royce Smaller-Companies Growth Fund | -5.01% | 19.53% | 21.81% | 16.97% | -32.45% | 6.61% | 49.45% | 23.68% | -10.81% | 17.71% |
NCLEX Nicholas Limited Edition Fund | -13.00% | -10.41% | 11.91% | 17.17% | -23.71% | 19.07% | 22.67% | 27.36% | -0.94% | 19.93% |
Returns By Period
In the year-to-date period, RYVPX achieves a -5.01% return, which is significantly higher than NCLEX's -13.00% return. Over the past 10 years, RYVPX has outperformed NCLEX with an annualized return of 9.90%, while NCLEX has yielded a comparatively lower 6.82% annualized return.
RYVPX
- 1D
- 3.79%
- 1M
- -6.68%
- YTD
- -5.01%
- 6M
- 1.16%
- 1Y
- 23.45%
- 3Y*
- 13.90%
- 5Y*
- 0.38%
- 10Y*
- 9.90%
NCLEX
- 1D
- 1.71%
- 1M
- -8.10%
- YTD
- -13.00%
- 6M
- -15.05%
- 1Y
- -16.29%
- 3Y*
- -1.57%
- 5Y*
- -2.35%
- 10Y*
- 6.82%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
RYVPX vs. NCLEX - Expense Ratio Comparison
RYVPX has a 1.49% expense ratio, which is higher than NCLEX's 0.85% expense ratio.
Return for Risk
RYVPX vs. NCLEX — Risk / Return Rank
RYVPX
NCLEX
RYVPX vs. NCLEX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Royce Smaller-Companies Growth Fund (RYVPX) and Nicholas Limited Edition Fund (NCLEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RYVPX | NCLEX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.94 | -0.79 | +1.72 |
Sortino ratioReturn per unit of downside risk | 1.45 | -1.07 | +2.52 |
Omega ratioGain probability vs. loss probability | 1.18 | 0.88 | +0.31 |
Calmar ratioReturn relative to maximum drawdown | 1.61 | -0.73 | +2.34 |
Martin ratioReturn relative to average drawdown | 5.43 | -1.99 | +7.42 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| RYVPX | NCLEX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.94 | -0.79 | +1.72 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.01 | -0.12 | +0.14 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.40 | 0.36 | +0.04 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.45 | 0.50 | -0.05 |
Correlation
The correlation between RYVPX and NCLEX is 0.89, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
RYVPX vs. NCLEX - Dividend Comparison
RYVPX's dividend yield for the trailing twelve months is around 17.67%, more than NCLEX's 8.66% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RYVPX Royce Smaller-Companies Growth Fund | 17.67% | 16.79% | 2.92% | 0.00% | 4.34% | 34.97% | 10.32% | 3.47% | 45.66% | 20.89% | 11.40% | 24.57% |
NCLEX Nicholas Limited Edition Fund | 8.66% | 7.53% | 2.51% | 2.43% | 6.22% | 16.44% | 5.10% | 5.66% | 10.72% | 7.97% | 10.68% | 8.05% |
Drawdowns
RYVPX vs. NCLEX - Drawdown Comparison
The maximum RYVPX drawdown since its inception was -59.03%, which is greater than NCLEX's maximum drawdown of -48.68%. Use the drawdown chart below to compare losses from any high point for RYVPX and NCLEX.
Loading graphics...
Drawdown Indicators
| RYVPX | NCLEX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -59.03% | -48.68% | -10.35% |
Max Drawdown (1Y)Largest decline over 1 year | -15.22% | -21.36% | +6.14% |
Max Drawdown (5Y)Largest decline over 5 years | -48.19% | -28.50% | -19.69% |
Max Drawdown (10Y)Largest decline over 10 years | -48.19% | -35.79% | -12.40% |
Current DrawdownCurrent decline from peak | -12.01% | -27.21% | +15.20% |
Average DrawdownAverage peak-to-trough decline | -13.24% | -8.21% | -5.03% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.52% | 7.84% | -3.32% |
Volatility
RYVPX vs. NCLEX - Volatility Comparison
Royce Smaller-Companies Growth Fund (RYVPX) has a higher volatility of 8.37% compared to Nicholas Limited Edition Fund (NCLEX) at 5.11%. This indicates that RYVPX's price experiences larger fluctuations and is considered to be riskier than NCLEX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| RYVPX | NCLEX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.37% | 5.11% | +3.26% |
Volatility (6M)Calculated over the trailing 6-month period | 15.85% | 12.33% | +3.52% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.10% | 19.73% | +4.37% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.32% | 19.47% | +6.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.87% | 19.16% | +5.71% |